SARS-CoV-2 can enter human cells through two entry receptors, angiotensin I-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), and infection with the virus can lead to severe adverse outcomes such as acute respiratory distress and gastrointestinal syndromes13. Here, ACE2 is linked to infection.